Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXTBiotechnology
+$0.46 today
- Market cap
- $89.11M
- Beta
- 1.05
- P/E (TTM)
- -11.1
- EPS (TTM)
- -$0.67
Volume 0.61M
Average 0.12M
LIXT Total Non-current Assets
All assets not expected to be converted to cash within one year.
Lixte Biotechnology Holdings, Inc.NASDAQ: LIXT
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets remains negative
Q1 FY2026 total non-current assets was $7.46M, compared with $0 a year earlier.
Context
- Total non-current assets amounted to 68.6% of total assets at the end of Q1 FY2026, up 68.6 pp from a year earlier.
- Total non-current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 7.56M USD
- Year-over-year change
- +6990.7%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.56M | +6990.7% |
| FY2024 | 2024-12-31 | 106.55K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Total Non-current Assets vs competitors
How LIXT compares with its peers on the latest reported figures
- LIXT's Mar 2026 total non-current assets of $7.46M is the highest of the 2 companies compared; the peer median is $2.95M.
- Total non-current assets amounts to 68.6% of total assets for LIXT, versus a peer median of 9.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $7.46M | — | — | 68.6% | |
| Mar 2026 | $2.95M | +50.1% | -4.6% | 9.6% | |
| Peer median (excluding LIXT) | $2.95M | +50.1% | -4.6% | 9.6% | |
Competitors are the stored peer set for LIXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXT
Intrinsic Alpha fair value
Locked
Current Price
$7.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.